A carregar...
Targeting IL4/IL4R for the treatment of epithelial cancer metastasis
While progress has been made in treating primary epithelial tumors, metastatic tumors remain largely incurable and still account for 85–90% of all cancer-related deaths. Interleukin-4 (IL4), a Th2 cytokine, and the IL4/IL4 receptor (IL4R) interaction have well defined roles in the immune system. Yet...
Na minha lista:
| Publicado no: | Clin Exp Metastasis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4651701/ https://ncbi.nlm.nih.gov/pubmed/26385103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-015-9747-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|